Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BHA issues reminder on administration of corticosteroids
Vets are being urged to draw their attention to published advice regarding the administration of corticosteroids.
Corticosteroids are prohibited substances on race day

Vets are being urged to draw their attention to published advice regarding the administration of corticosteroids.

In January 2015, The British Horseracing Authority (BHA) introduced a 14 day stand-down period following administration of any intra-articular corticosteroids.

The rules state: “The horse must not have been administered any intra-articular corticosteroid on the day of the race or on any of the fourteen days before the day of the race in which the horse is declared to run.”

The BHA advises that this mandatory stand-down period should not be confused with a Detection Time or with a Withdrawal Period.

“The difference between a Detection Time and a Withdrawal Period should be understood, as the two are different,” writes the BHA. “To decide a Withdrawal Period, an adequate safety margin should be added to a Detection Time. This safety margin should be chosen by the treating veterinary surgeon, using their professional judgement, and should take into account potential biological, pharmaceutical and pharmacological variation.

“This clearly makes a discussion between a Trainer and their veterinary surgeon essential when considering administration of any medication which is a Prohibited Substance on Raceday.”

Trainers who would like to establish that medication given for veterinary treatment has cleared from a horse’s system before a race are invited to contact the Equine Health and Welfare Department at equine@britishhorsracing.com or 020 7152 0010. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.